Tyra Biosciences (TYRA) analyst forecast and price target
Analyst forecast
Consensus of 15 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $29.00 from $30.00 | Sep 22, 2026 |
| Oppenheimer | Maintained | Outperform | $40.00 from $50.00 | Sep 22, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 from $45.00 | Sep 10, 2026 |
| Wedbush | Maintained | Outperform | $53.00 | Sep 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $45.00 | Sep 4, 2026 |
| Jones Trading | Initiated Coverage | Buy | $56.00 | Jun 17, 2026 |
| B of A Securities | Maintained | Buy | $42.00 from $37.00 | Jun 10, 2026 |
| Wolfe Research | Initiated Coverage | Peer Perform | — | May 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $45.00 | May 14, 2026 |
| Guggenheim | Initiated Coverage | Buy | $54.00 | Apr 15, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $50.00 | Apr 6, 2026 |
| Piper Sandler | Maintained | Overweight | $56.00 from $42.00 | Mar 20, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | Feb 24, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $45.00 from $30.00 | Feb 17, 2026 |
| Wedbush | Maintained | Outperform | $53.00 from $37.00 | Feb 13, 2026 |
| Jefferies | Maintained | Buy | $43.00 from $32.00 | Feb 3, 2026 |
| Oppenheimer | Maintained | Outperform | $50.00 from $36.00 | Feb 3, 2026 |
| Barclays | Initiated Coverage | Overweight | $59.00 | Jan 28, 2026 |
| Piper Sandler | Maintained | Overweight | $42.00 from $33.00 | Jan 23, 2026 |
| Wedbush | Maintained | Outperform | $37.00 from $30.00 | Dec 16, 2025 |
Frequently asked questions
What is the price target for TYRA stock?
The average 12-month analyst price target for Tyra Biosciences (TYRA) is $40.67, with a high estimate of $53.00 and a low of $29.00, across 3 analysts.
Is TYRA a buy, sell, or hold?
Analysts covering Tyra Biosciences currently average a Buy rating: 14 buy, 1 hold and 0 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for TYRA?
The average price target of $40.67 implies 117.47% upside from the last price of $18.70.
What is the latest analyst rating on TYRA?
On Sep 22, 2026, HC Wainwright & Co. maintained Tyra Biosciences at Buy with a price target of $29.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.